Mark E. Diebel

2.9k total citations · 3 hit papers
13 papers, 2.3k citations indexed

About

Mark E. Diebel is a scholar working on Oncology, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark E. Diebel has authored 13 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Critical Care and Intensive Care Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark E. Diebel's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Blood transfusion and management (3 papers) and Cancer Cells and Metastasis (3 papers). Mark E. Diebel is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers), Blood transfusion and management (3 papers) and Cancer Cells and Metastasis (3 papers). Mark E. Diebel collaborates with scholars based in United States, France and Egypt. Mark E. Diebel's co-authors include Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Gabriela Dontu, Max S. Wicha, Christophe Ginestier, Julien Wicinski, Patrice Viens, Flora Iovino, Giorgio Stassi and Luc Xerri and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mark E. Diebel

12 papers receiving 2.2k citations

Hit Papers

Breast Cancer Cell Lines Contain Functional Cancer Stem C... 2009 2026 2014 2020 2009 2010 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
    2009 935 citations Emmanuelle Charafe‐Jauffret, Christophe Ginestier et al. Cancer Research profile →
  2. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
    2010 588 citations Christophe Ginestier, Suling Liu et al. Journal of Clinical Investigation profile →
  3. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
    2009 575 citations Emmanuelle Charafe‐Jauffret, Christophe Ginestier et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Diebel United States 10 1.7k 1.0k 646 329 169 13 2.3k
Shui Ping Tu China 19 940 0.6× 997 1.0× 433 0.7× 435 1.3× 178 1.1× 23 2.1k
Srinivas Malladi United States 12 952 0.6× 981 0.9× 384 0.6× 576 1.8× 211 1.2× 28 1.9k
Hazem Ghebeh Saudi Arabia 24 1.8k 1.0× 733 0.7× 373 0.6× 954 2.9× 295 1.7× 52 2.6k
Mara H. Sherman United States 19 1.1k 0.6× 1.4k 1.4× 807 1.2× 511 1.6× 139 0.8× 35 2.9k
Federica Papaccio Italy 21 909 0.5× 1.0k 1.0× 594 0.9× 185 0.6× 293 1.7× 42 2.0k
Jason R. Pitarresi United States 15 830 0.5× 959 0.9× 467 0.7× 358 1.1× 256 1.5× 36 1.8k
Jianhua Huang China 20 1.0k 0.6× 723 0.7× 353 0.5× 785 2.4× 192 1.1× 41 2.0k
Mathias Wenes Belgium 16 937 0.6× 1.1k 1.0× 771 1.2× 1.2k 3.7× 220 1.3× 20 2.6k
Janelle Simon United States 11 727 0.4× 993 1.0× 379 0.6× 504 1.5× 132 0.8× 13 2.0k

Countries citing papers authored by Mark E. Diebel

Since Specialization
Citations

This map shows the geographic impact of Mark E. Diebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Diebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Diebel more than expected).

Fields of papers citing papers by Mark E. Diebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Diebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Diebel. The network helps show where Mark E. Diebel may publish in the future.

Co-authorship network of co-authors of Mark E. Diebel

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Diebel. A scholar is included among the top collaborators of Mark E. Diebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Diebel. Mark E. Diebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sugawa, Choichi, et al.. (2020). Acute hemorrhagic rectal ulcer: Experience in 11 patients at an urban acute care center in the USA. Medicine. 99(18). e19836–e19836. 9 indexed citations
2.
Diebel, Mark E., Lawrence N. Diebel, & David M. Liberati. (2019). Protective effects of plasma products on the endothelial-glycocalyx barrier following trauma-hemorrhagic shock: Is sphingosine-1 phosphate responsible?. The Journal of Trauma: Injury, Infection, and Critical Care. 87(5). 1061–1069. 23 indexed citations
3.
Diebel, Lawrence N., et al.. (2018). Acute hyperglycemia exacerbates trauma-induced endothelial and glycocalyx injury: An in vitro model. The Journal of Trauma: Injury, Infection, and Critical Care. 85(5). 960–967. 17 indexed citations
4.
Diebel, Mark E., et al.. (2017). The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation. The Journal of Trauma: Injury, Infection, and Critical Care. 84(1). 75–80. 43 indexed citations
5.
Diebel, Mark E., Lawrence N. Diebel, & David M. Liberati. (2016). Gender dimorphism in adipose tissue response to stress conditions. The Journal of Trauma: Injury, Infection, and Critical Care. 81(6). 1028–1034. 8 indexed citations
6.
Diebel, Mark E., Lawrence N. Diebel, & David M. Liberati. (2016). Tranexamic acid and the gut barrier: Protection by inhibition of trypsin uptake and activation of downstream intestinal proteases. The American Journal of Surgery. 213(3). 489–493. 6 indexed citations
7.
Diebel, Mark E., Lawrence N. Diebel, Charles W. Manke, & David M. Liberati. (2015). Estrogen modulates intestinal mucus physiochemical properties and protects against oxidant injury. The Journal of Trauma: Injury, Infection, and Critical Care. 78(1). 94–99. 33 indexed citations
8.
Diebel, Mark E., et al.. (2015). Early tranexamic acid administration. The Journal of Trauma: Injury, Infection, and Critical Care. 79(6). 1015–1022. 15 indexed citations
9.
Diebel, Mark E., et al.. (2013). 963. Critical Care Medicine. 41. A242–A242.
10.
Diebel, Mark E., Lawrence N. Diebel, & David M. Liberati. (2011). Gender Dimorphism in the Gut: Mucosal Protection by Estrogen Stimulation of IgA Transcytosis. The Journal of Trauma: Injury, Infection, and Critical Care. 71(2). 474–479. 21 indexed citations
11.
Ginestier, Christophe, Suling Liu, Mark E. Diebel, et al.. (2010). CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. Journal of Clinical Investigation. 120(2). 485–497. 588 indexed citations breakdown →
12.
Charafe‐Jauffret, Emmanuelle, Christophe Ginestier, Flora Iovino, et al.. (2009). Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer. Clinical Cancer Research. 16(1). 45–55. 575 indexed citations breakdown →
13.
Charafe‐Jauffret, Emmanuelle, Christophe Ginestier, Flora Iovino, et al.. (2009). Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature. Cancer Research. 69(4). 1302–1313. 935 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shui Ping Tu Breakdown of academic impact, for papers by Srinivas Malladi Breakdown of academic impact, for papers by Hazem Ghebeh Breakdown of academic impact, for papers by Mara H. Sherman Breakdown of academic impact, for papers by Federica Papaccio Breakdown of academic impact, for papers by Jason R. Pitarresi Breakdown of academic impact, for papers by Jianhua Huang Breakdown of academic impact, for papers by Mathias Wenes Breakdown of academic impact, for papers by Janelle Simon
Rankless by CCL
2026